Publication
Harnessing necroptosis via RIPK1 degradation to potentiate radio-immunotherapy in cervical cancer.
Tong Wu, Bin Lv, Han Wang, Guangping He, Yuandong Fu, Xiuru Ji, Yulian Zeng, Dalong Ni, Junjun Qiu, Keqin Hua
Bioactive materialsJan 1, 2027PMID 42668673doi:10.1016/j.bioactmat.2026.08.020 PMC13524860Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Immune checkpoint inhibitors (ICIs) are first-line therapy for cervical cancer (CC), yet their efficacy is limited to a subset of patients owing to low tumor immunogenicity. Single-cell RNA sequencing revealed that CC patients exhibiting robust immune responses following radiotherapy (RT) showed…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Cervical Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.